Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
***For external use only
.png.jpg)
doi: 10.1055/s-2007-970574
GLP-1 Agonists Market Size, Share & Trends Analysis Report By Product (Branded GLP-1 Agonists, Dual / Triple, Biosimilars & Generic GLP-1 Agonists Agonists), By Indication (Type 2 Diabetes Mellitus, Obesity / Overweight Management, Cardiovascular & Metabolic Related Indications, Other Emerging Indications (e.g., NASH, Alzheimers-related)), By Route of Administration, By Distribution Channel, By Region and By Segments Forecasts, 2025-2034 GLP-1 Agonists Market Size is valued at USD 43.1 Bn in 2024 and is predicted to reach USD 260.1 Bn by the year 2034 at an 19.9% CAGR during the forecast period for 2025-2034
The UV fluence was calculated using the following equation: For the UV/H 2 O 2 process, H 2 O 2 was added just prior to the irradiation
US$ 20.37
US$ 20.92
US$ 23.32
US$ 20.35
US$ 29.85
US$ 28.78
US$ 20.59
US$ 22.93
US$ 21.63
